Back to User profile » Dr Meiyuan Dong
Papers published by Dr Meiyuan Dong:
The Renal Micro-Vasculopathy and Systemic Aldosterone-Renin Ratio (ARR) in Type 2 Diabetic Patients—A Retrospective Real-World Study
Wen S, Xu Z, Gong M, Wang C, Yuan Y, Li Y, Dong M, Wang C, Xu D, Yuan X, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4229-4245
Published Date: 14 November 2025
The Therapeutic Effect and Mechanism of Traditional Chinese Medicine in Type 2 Diabetes Mellitus and Its Complications
Wen S, Zhang H, Huang X, Wang C, Dong M, Wang C, Xu C, Yuan Y, Li Y, Zhou L, Yuan X
Diabetes, Metabolic Syndrome and Obesity 2025, 18:1599-1627
Published Date: 15 May 2025
The Relationship Between Computerized Face and Tongue Image Segmentation and Metabolic Parameters in Patients with Type 2 Diabetes Based on Machine Learning
Wen S, Li Y, Xu C, Jin J, Xu Z, Yuan Y, Chen L, Ren Y, Gong M, Wang C, Dong M, Zhou Y, Yuan X, Li F, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2024, 17:4049-4068
Published Date: 29 October 2024
Low T3 Syndrome is Associated with Imbalance of Bone Turnover Biomarker in Patients with Type 2 Diabetes
Xu C, Wen S, Xu Z, Dong M, Yuan Y, Li Y, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2024, 17:3667-3682
Published Date: 9 October 2024
The Implication of Elevated Serum Myoglobin Level in Acute Diabetic Complications of Ketoacidosis and Hyperglycemic Hyperosmolar State: A Real-World Study
Xu C, Wen S, Gong M, Dong M, Yuan Y, Li Y, Zhou M, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2024, 17:2639-2653
Published Date: 1 July 2024
The Metabolic Characteristics of Patients at the Risk for Diabetic Foot Ulcer: A Comparative Study of Diabetic Patients with and without Diabetic Foot
Li X, Wen S, Dong M, Yuan Y, Gong M, Wang C, Yuan X, Jin J, Zhou M, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2023, 16:3197-3211
Published Date: 17 October 2023
Therapeutic Approaches for Nonalcoholic Fatty Liver Disease: Established Targets and Drugs
Huang X, Chen H, Wen S, Dong M, Zhou L, Yuan X
Diabetes, Metabolic Syndrome and Obesity 2023, 16:1809-1819
Published Date: 21 June 2023
The Association Between Sarcopenia and Diabetes: From Pathophysiology Mechanism to Therapeutic Strategy
Chen H, Huang X, Dong M, Wen S, Zhou L, Yuan X
Diabetes, Metabolic Syndrome and Obesity 2023, 16:1541-1554
Published Date: 30 May 2023
The Mechanism of Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Uric Acid in Type 2 Diabetes Mellitus
Dong M, Chen H, Wen S, Yuan Y, Yang L, Xu D, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2023, 16:437-445
Published Date: 14 February 2023
The Neuronal and Non-Neuronal Pathways of Sodium-Glucose Cotransporter-2 Inhibitor on Body Weight-Loss and Insulin Resistance
Dong M, Chen H, Wen S, Yuan Y, Yang L, Li Y, Yuan X, Xu D, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2023, 16:425-435
Published Date: 14 February 2023
The Relationship Between the Blood-Brain-Barrier and the Central Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors
Dong M, Wen S, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2022, 15:2583-2597
Published Date: 22 August 2022